VeriMomglycyrrhiza glabra leaf extract hamilelikte güvenli mi?
No EU Annex II/III restriction or harmonised CLP (Annex VI) reproductive CMR classification found; CIR lists the ingredient as a cosmetic ingredient (no CIR reproductive prohibition) and PubMed literature on leaf extracts shows antifungal/biological activity but no reproductive/developmental toxicity data from dermal exposure. ECHA substance info lists company CLP notifications (flammability, and some supplier REACH/registration notes) but these are not harmonised reproductive H‑codes; company self‑notifications do not justify assuming harmonised H361/H360. Topical absorption is possible for some constituents (flavonoids/glycyrrhetinic derivatives) so I assign low measurable exposure for pregnant adults. Sources: CIR ingredient page; ECHA substance infocard; PubMed leaf‑extract studies; supplier/spec sheets.
Pregnancy-safe products containing glycyrrhiza glabra leaf extract
Related ingredients
Frequently asked questions
- glycyrrhiza glabra leaf extract hamilelikte güvenli mi?
- No EU Annex II/III restriction or harmonised CLP (Annex VI) reproductive CMR classification found; CIR lists the ingredient as a cosmetic ingredient (no CIR reproductive prohibition) and PubMed literature on leaf extracts shows antifungal/biological activity but no reproductive/developmental toxicity data from dermal exposure. ECHA substance info lists company CLP notifications (flammability, and some supplier REACH/registration notes) but these are not harmonised reproductive H‑codes; company self‑notifications do not justify assuming harmonised H361/H360. Topical absorption is possible for some constituents (flavonoids/glycyrrhetinic derivatives) so I assign low measurable exposure for pregnant adults. Sources: CIR ingredient page; ECHA substance infocard; PubMed leaf‑extract studies; supplier/spec sheets.
- glycyrrhiza glabra leaf extract emzirirken güvenli mi?
- No evidence of a harmonised reproductive/lactation hazard or EU ban/restriction for cosmetic topical use. Clinical concerns around licorice/Glycyrrhiza relate to oral glycyrrhizin ingestion (systemic mineralocorticoid effects) rather than documented hazards from topical cosmetic use; however measurable systemic absorption cannot be ruled out for certain constituents so exposure is rated low but measurable. Breastfeeding guidance in herbal safety summaries cautions about oral licorice but does not provide clear evidence of harm from topical cosmetic use. Sources: CIR ingredient page; ECHA infocard; herbal safety reviews/consumer guidance.
- glycyrrhiza glabra leaf extract bebek cildi için güvenli mi?
- No evidence of harmonised reproductive/teratogenic classification or EU cosmetic ban/restriction specific to Glycyrrhiza glabra leaf/root extracts. Dermal absorption for adults is low–but not zero; because infant skin (0–3 yr) has higher surface‑area‑to‑weight and immature barrier, I increased exposure by +1. There are no infant‑specific dermal safety studies located for this INCI; therefore the risk scoring reflects higher exposure but no direct hazard evidence. Sources: CIR ingredient page; PubMed searches (no infant dermal reproductive/developmental studies found); supplier/spec sheets noting composition variability.
- VeriMom glycyrrhiza glabra leaf extract nasıl puanlıyor?
- VeriMom glycyrrhiza glabra leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte glycyrrhiza glabra leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.